Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sherr

Showing results (161-170 of 245) with videos related to

Pageof 25
Sort By:
AIDS (London, England)|November 23, 2000
Cost effectiveness of expanded antenatal HIV testing in LondonM J Postma, E J Beck, C A Hankins, et al.
Diabetes Technology & Therapeutics|December 21, 2016
Mitigating Reductions in Glucose During Exercise on Closed-Loop Insulin Delivery: The Ex-Snacks StudyNeha S Patel, Michelle A Van Name, Eda Cengiz, et al.
Diabetes Care|October 6, 2022
Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes AssociationJennifer L Sherr, Lutz Heinemann, G Alexander Fleming, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2023
OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive IndividualsAlyssa Ylescupidez, Cate Speake, Susan L Pietropaolo, et al.
Diabetologia|October 5, 2022
Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes AssociationJennifer L Sherr, Lutz Heinemann, G Alexander Fleming, et al.
Diabetologia|March 13, 2026
Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working GroupDaniela Bruttomesso, John R Petrie, Mark Evans, et al.
Pediatric Diabetes|December 5, 2022
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin deliveryJennifer L Sherr, Melissa Schoelwer, Tiago Jeronimo Dos Santos, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|June 7, 2022
Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With DiabetesCari Berget, Jennifer L Sherr, Daniel J DeSalvo, et al.
Diabetes Technology & Therapeutics|July 1, 2025
Practical Considerations and Implementation of Automated Insulin Delivery SystemsLaurel H Messer, Gregory P Forlenza, Linda Gonder-Frederick, et al.
Diabetes Technology & Therapeutics|June 23, 2026
Percent Time Below Range Is Strongly Associated with Clinically Important Level 2 Hypoglycemia Events in Individuals with Type 1 DiabetesPeter Calhoun, Richard T Liggins, Zoey Li, et al.
Pageof 25

Showing results (161-170 of 245) with videos related to

Sort By:
Pageof 25
AIDS (London, England)|November 23, 2000
Cost effectiveness of expanded antenatal HIV testing in LondonM J Postma, E J Beck, C A Hankins, et al.
Diabetes Technology & Therapeutics|December 21, 2016
Mitigating Reductions in Glucose During Exercise on Closed-Loop Insulin Delivery: The Ex-Snacks StudyNeha S Patel, Michelle A Van Name, Eda Cengiz, et al.
Diabetes Care|October 6, 2022
Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes AssociationJennifer L Sherr, Lutz Heinemann, G Alexander Fleming, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2023
OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive IndividualsAlyssa Ylescupidez, Cate Speake, Susan L Pietropaolo, et al.
Diabetologia|October 5, 2022
Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes AssociationJennifer L Sherr, Lutz Heinemann, G Alexander Fleming, et al.
Diabetologia|March 13, 2026
Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working GroupDaniela Bruttomesso, John R Petrie, Mark Evans, et al.
Pediatric Diabetes|December 5, 2022
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin deliveryJennifer L Sherr, Melissa Schoelwer, Tiago Jeronimo Dos Santos, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|June 7, 2022
Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With DiabetesCari Berget, Jennifer L Sherr, Daniel J DeSalvo, et al.
Diabetes Technology & Therapeutics|July 1, 2025
Practical Considerations and Implementation of Automated Insulin Delivery SystemsLaurel H Messer, Gregory P Forlenza, Linda Gonder-Frederick, et al.
Diabetes Technology & Therapeutics|June 23, 2026
Percent Time Below Range Is Strongly Associated with Clinically Important Level 2 Hypoglycemia Events in Individuals with Type 1 DiabetesPeter Calhoun, Richard T Liggins, Zoey Li, et al.
Pageof 25